Works matching AU Hase, Tetsunari

Results: 48
    1
    2

    Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy?

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2016, v. 142, n. 7, p. 1629, doi. 10.1007/s00432-016-2170-z
    By:
    • Kato, Toshio;
    • Morise, Masahiro;
    • Ando, Masahiko;
    • Kojima, Eiji;
    • Ogasawara, Tomohiko;
    • Suzuki, Ryujiro;
    • Shindoh, Joe;
    • Matsumoto, Masami;
    • Sugino, Yasuteru;
    • Ogawa, Masahiro;
    • Nozaki, Yasuhiro;
    • Hase, Tetsunari;
    • Kondo, Masashi;
    • Saito, Hiroshi;
    • Hasegawa, Yoshinori
    Publication type:
    Article
    3

    Endobronchial ultrasound transbronchial needle aspiration in older people.

    Published in:
    Geriatrics & Gerontology International, 2013, v. 13, n. 4, p. 986, doi. 10.1111/ggi.12043
    By:
    • Okachi, Shotaro;
    • Imai, Naoyuki;
    • Imaizumi, Kazuyoshi;
    • Hase, Tetsunari;
    • Shindo, Yuichiro;
    • Sakamoto, Koji;
    • Aso, Hiromichi;
    • Wakahara, Keiko;
    • Hashimoto, Izumi;
    • Ito, Satoru;
    • Hashimoto, Naozumi;
    • Sato, Mitsuo;
    • Kondo, Masashi;
    • Hasegawa, Yoshinori
    Publication type:
    Article
    4

    Elevated TSH Level, TgAb, and Prior Use of Ramucirumab or TKIs as Risk Factors for Thyroid Dysfunction in PD-L1 Blockade.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 10, p. e4115, doi. 10.1210/clinem/dgac467
    By:
    • Tomoko Kobayashi;
    • Shintaro Iwama;
    • Ayana Yamagami;
    • Yoshinori Yasuda;
    • Takayuki Okuji;
    • Masaaki Ito;
    • Xin Zhou;
    • Masahiko Ando;
    • Takeshi Onoue;
    • Takashi Miyata;
    • Mariko Sugiyama;
    • Daisuke Hagiwara;
    • Hidetaka Suga;
    • Ryoichi Banno;
    • Tetsunari Hase;
    • Masahiro Morise;
    • Takanori Ito;
    • Toyone Kikumori;
    • Megumi Inoue;
    • Yuichi Ando
    Publication type:
    Article
    5

    Increased Risk of Thyroid Dysfunction by PD-1 and CTLA-4 Blockade in Patients Without Thyroid Autoantibodies at Baseline.

    Published in:
    Journal of Clinical Endocrinology & Metabolism, 2022, v. 107, n. 4, p. e1620, doi. 10.1210/clinem/dgab829
    By:
    • Shintaro Iwama;
    • Tomoko Kobayashi;
    • Yoshinori Yasuda;
    • Takayuki Okuji;
    • Masaaki Ito;
    • Masahiko Ando;
    • Xin Zhou;
    • Ayana Yamagami;
    • Takeshi Onoue;
    • Yohei Kawaguchi;
    • Takashi Miyata;
    • Mariko Sugiyama;
    • Hiroshi Takagi;
    • Daisuke Hagiwara;
    • Hidetaka Suga;
    • Ryoichi Banno;
    • Tetsunari Hase;
    • Masahiro Morise;
    • Keiko Wakahara;
    • Kenji Yokota
    Publication type:
    Article
    6
    7
    8

    Development of an immuno-wall device for the rapid and sensitive detection of EGFR mutations in tumor tissues resected from lung cancer patients.

    Published in:
    PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241422
    By:
    • Yogo, Naoyuki;
    • Hase, Tetsunari;
    • Kasama, Toshihiro;
    • Nishiyama, Keine;
    • Ozawa, Naoya;
    • Hatta, Takahiro;
    • Shibata, Hirofumi;
    • Sato, Mitsuo;
    • Komeda, Kazuki;
    • Kawabe, Nozomi;
    • Matsuoka, Kohei;
    • Chen-Yoshikawa, Toyofumi Fengshi;
    • Kaji, Noritada;
    • Tokeshi, Manabu;
    • Baba, Yoshinobu;
    • Hasegawa, Yoshinori
    Publication type:
    Article
    9

    A case of antiprogrammed death‐ligand 1 antibody‐induced multisystem immune‐related adverse events with pancreatitis and steroid‐resistant sclerosing cholangitis.

    Published in:
    Journal of Digestive Diseases, 2022, v. 23, n. 7, p. 404, doi. 10.1111/1751-2980.13122
    By:
    • Yamamoto, Takafumi;
    • Ito, Takanori;
    • Mizuno, Kazuyuki;
    • Shinya, Yokoyama;
    • Yamamoto, Kenta;
    • Imai, Norihiro;
    • Ishizu, Yoji;
    • Honda, Takashi;
    • Kawashima, Hiroki;
    • Matsui, Toshinori;
    • Hase, Tetsunari;
    • Hashimoto, Naozumi;
    • Ishigami, Masatoshi
    Publication type:
    Article
    10

    Efficacies of programmed cell death 1 ligand 1 blockade in non-small cell lung cancer patients with acquired resistance to prior programmed cell death 1 inhibitor and development of diabetic ketoacidosis caused by two different etiologies: a retrospective case series

    Published in:
    Endocrine Journal, 2021, v. 68, n. 5, p. 613, doi. 10.1507/endocrj.ej20-0769
    By:
    • Azusa Ishi;
    • Ichidai Tanaka;
    • Shintaro Iwama;
    • Toshihiro Sakakibara;
    • Toshinori Mastui;
    • Tomoko Kobayashi;
    • Tetsunari Hase;
    • Masahiro Morise;
    • Mitsuo Sato;
    • Hiroshi Arima;
    • Naozumi Hashimoto
    Publication type:
    Article
    11

    Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf120
    By:
    • Mizuno, Kazuyuki;
    • Ito, Takanori;
    • Sawada, Tsunaki;
    • Kobayashi, Tomoko;
    • Iwama, Shintaro;
    • Mori, Shoichiro;
    • Hase, Tetsunari;
    • Fukami, Yuki;
    • Furusawa, Kenji;
    • Yura, Yoshimitsu;
    • Morimoto, Ryota;
    • Sajiki, Ai Fujita;
    • Ushida, Hiroaki;
    • Kato, Noritoshi;
    • Maruyama, Shoichi;
    • Murohara, Toyoaki;
    • Katsuno, Masahisa;
    • Ishii, Makoto;
    • Akiyama, Masashi;
    • Arima, Hiroshi
    Publication type:
    Article
    12
    13

    Femoral bone metastasis is a poor prognostic factor in EGFR-TKIs-treated patients with EGFR -mutated non-small-cell lung cancer: a retrospective, multicenter cohort study.

    Published in:
    Therapeutic Advances in Medical Oncology, 2024, p. 1, doi. 10.1177/17588359241303090
    By:
    • Tanaka, Ichidai;
    • Hori, Kazumi;
    • Koyama, Junji;
    • Gen, Soei;
    • Morise, Masahiro;
    • Kodama, Yuta;
    • Matsui, Akira;
    • Miyazawa, Ayako;
    • Hase, Tetsunari;
    • Hibino, Yoshitaka;
    • Yokoyama, Toshihiko;
    • Kimura, Tomoki;
    • Yoshida, Norio;
    • Sato, Mitsuo;
    • Ishii, Makoto
    Publication type:
    Article
    14
    15
    16

    Adjustment of creatinine clearance for carboplatin dosing in Calvert's formula and clinical efficacy for lung cancer.

    Published in:
    Cancer Medicine, 2023, v. 12, n. 15, p. 15955, doi. 10.1002/cam4.6235
    By:
    • Hatta, Takahiro;
    • Hase, Tetsunari;
    • Hara, Toru;
    • Kimura, Tomoki;
    • Kojima, Eiji;
    • Abe, Takashi;
    • Horio, Yoshitsugu;
    • Goto, Yasuhiro;
    • Ozawa, Naoya;
    • Yogo, Naoyuki;
    • Shibata, Hirofumi;
    • Shimokata, Tomoya;
    • Oguri, Tetsuya;
    • Yamamoto, Masashi;
    • Yanagisawa, Kiyoshi;
    • Ando, Masahiko;
    • Ando, Yuichi;
    • Kondo, Masashi;
    • Ishii, Makoto;
    • Hasegawa, Yoshinori
    Publication type:
    Article
    17
    18

    Clustering using unsupervised machine learning to stratify the risk of immune‐related liver injury.

    Published in:
    Journal of Gastroenterology & Hepatology, 2023, v. 38, n. 2, p. 251, doi. 10.1111/jgh.16038
    By:
    • Yamamoto, Takafumi;
    • Morooka, Hikaru;
    • Ito, Takanori;
    • Ishigami, Masatoshi;
    • Mizuno, Kazuyuki;
    • Yokoyama, Shinya;
    • Yamamoto, Kenta;
    • Imai, Norihiro;
    • Ishizu, Yoji;
    • Honda, Takashi;
    • Yokota, Kenji;
    • Hase, Tetsunari;
    • Maeda, Osamu;
    • Hashimoto, Naozumi;
    • Ando, Yuichi;
    • Akiyama, Masashi;
    • Kawashima, Hiroki
    Publication type:
    Article
    19

    <sup>11</sup>C-methionine- and <sup>18</sup>F-FDG-PET double-negative metastatic brain tumor from lung adenocarcinoma with paradoxical high <sup>18</sup>F-FDG uptake: A case report.

    Published in:
    Surgical Neurology International, 2022, v. 13, p. 1, doi. 10.25259/SNI_264_2022
    By:
    • Kuniaki Tanahashi;
    • Masaki Hirano;
    • Lushun Chalise;
    • Takahiko Tsugawa;
    • Yuka Okumura;
    • Tetsunari Hase;
    • Fumiharu Ohka;
    • Kazuya Motomura;
    • Kazuhito Takeuchi;
    • Yuichi Nagata;
    • Norimoto Nakahara;
    • Naozumi Hashimoto;
    • Ryuta Saito
    Publication type:
    Article
    20

    Circulating microRNA Panel for Prediction of Recurrence and Survival in Early-Stage Lung Adenocarcinoma.

    Published in:
    International Journal of Molecular Sciences, 2024, v. 25, n. 4, p. 2331, doi. 10.3390/ijms25042331
    By:
    • Tai, Mei-Chee;
    • Bantis, Leonidas E.;
    • Parhy, Gargy;
    • Kato, Taketo;
    • Tanaka, Ichidai;
    • Chow, Chi-Wan;
    • Fujimoto, Junya;
    • Behrens, Carmen;
    • Hase, Tetsunari;
    • Kawaguchi, Koji;
    • Fahrmann, Johannes F.;
    • Ostrin, Edwin J.;
    • Yokoi, Kohei;
    • Chen-Yoshikawa, Toyofumi F.;
    • Hasegawa, Yoshinori;
    • Hanash, Samir M.;
    • Wistuba, Ignacio I.;
    • Taguchi, Ayumu
    Publication type:
    Article
    21
    22

    Combined use of tyrosine kinase inhibitors with PD-(L)1 blockade increased the risk of thyroid dysfunction in PD-(L)1 blockade: a prospective study.

    Published in:
    Cancer Immunology, Immunotherapy, 2024, v. 73, n. 8, p. 1, doi. 10.1007/s00262-024-03733-2
    By:
    • Kobayashi, Tomoko;
    • Iwama, Shintaro;
    • Yamagami, Ayana;
    • Izuchi, Tetsushi;
    • Suzuki, Koji;
    • Otake, Koki;
    • Yasuda, Yoshinori;
    • Ando, Masahiko;
    • Onoue, Takeshi;
    • Miyata, Takashi;
    • Sugiyama, Mariko;
    • Hagiwara, Daisuke;
    • Suga, Hidetaka;
    • Banno, Ryoichi;
    • Hase, Tetsunari;
    • Nishio, Naoki;
    • Mori, Shoichiro;
    • Shimokata, Tomoya;
    • Sano, Tomoyasu;
    • Niimi, Kaoru
    Publication type:
    Article
    23

    Immune-related Liver Injury is a Poor Prognostic Factor in Patients with Nonsmall Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

    Published in:
    Cancer Investigation, 2022, v. 40, n. 2, p. 189, doi. 10.1080/07357907.2021.1994586
    By:
    • Yamamoto, Takafumi;
    • Ito, Takanori;
    • Hase, Tetsunari;
    • Ishigami, Masatoshi;
    • Mizuno, Kazuyuki;
    • Yamamoto, Kenta;
    • Imai, Norihiro;
    • Ishizu, Yoji;
    • Honda, Takashi;
    • Shibata, Hirofumi;
    • Hatta, Takahiro;
    • Yogo, Naoyuki;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Abe, Takashi;
    • Kawashima, Hiroki;
    • Hashimoto, Naozumi;
    • Fujishiro, Mitsuhiro
    Publication type:
    Article
    24
    25
    26
    27

    Combined PD-1 and CTLA-4 Blockade Increases the Risks of Multiple Pituitary Hormone Deficiency and Isolated Adrenocorticotropic Deficiency: A Prospective Study.

    Published in:
    Endocrinology & Metabolism, 2025, v. 40, n. 3, p. 459, doi. 10.3803/EnM.2024.2180
    By:
    • Shintaro Iwama;
    • Tomoko Kobayashi;
    • Tetsushi Izuchi;
    • Koji Suzuki;
    • Takanori Murase;
    • Masahiko Ando;
    • Tomoko Handa;
    • Takeshi Onoue;
    • Takashi Miyata;
    • Mariko Sugiyama;
    • Daisuke Hagiwara;
    • Hidetaka Suga;
    • Ryoichi Banno;
    • Tetsunari Hase;
    • Shoichiro Mori;
    • Tomoyasu Sano;
    • Shusuke Akamatsu;
    • Masashi Akiyama;
    • Makoto Ishii;
    • Hiroshi Arima
    Publication type:
    Article
    28

    Development of pituitary dysfunction and destructive thyroiditis is associated with better survival in non-small cell lung cancer patients treated with programmed cell death-1 inhibitors: a prospective study with immortal time bias correction.

    Published in:
    Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1490042
    By:
    • Suzuki, Koji;
    • Kobayashi, Tomoko;
    • Izuchi, Tetsushi;
    • Otake, Koki;
    • Ando, Masahiko;
    • Handa, Tomoko;
    • Miyata, Takashi;
    • Sugiyama, Mariko;
    • Onoue, Takeshi;
    • Hagiwara, Daisuke;
    • Suga, Hidetaka;
    • Banno, Ryoichi;
    • Hase, Tetsunari;
    • Inoue, Megumi;
    • Ishii, Makoto;
    • Arima, Hiroshi;
    • Iwama, Shintaro
    Publication type:
    Article
    29
    30

    Thyroid autoantibodies at baseline predict longer survival in non-small cell lung cancer patients treated with anti-programmed cell death-1 blockade: a prospective study.

    Published in:
    Nagoya Journal of Medical Science, 2024, v. 86, n. 3, p. 452, doi. 10.18999/nagjms.86.3.452
    By:
    • Takayuki Okuji;
    • Shintaro Iwama;
    • Tomoko Kobayashi;
    • Yoshinori Yasuda;
    • Masaaki Ito;
    • Ayana Yamagami;
    • Masahiko Ando;
    • Tetsunari Hase;
    • Hirofumi Shibata;
    • Takahiro Hatta;
    • Xin Zhou;
    • Takeshi Onoue;
    • Yohei Kawaguchi;
    • Takashi Miyata;
    • Mariko Sugiyama;
    • Daisuke Hagiwara;
    • Hidetaka Suga;
    • Ryoichi Banno;
    • Yuichi Ando;
    • Naozumi Hashimoto
    Publication type:
    Article
    31
    32

    Abdominal pain accompanied by elevated serum inflammatory markers and biliary enzymes for diagnosing immune checkpoint inhibitor-induced sclerosing cholangitis.

    Published in:
    Investigational New Drugs, 2023, v. 41, n. 3, p. 512, doi. 10.1007/s10637-023-01366-3
    By:
    • Yamamoto, Takafumi;
    • Mizuno, Kazuyuki;
    • Ito, Takanori;
    • Yokoyama, Shinya;
    • Yamamoto, Kenta;
    • Imai, Norihiro;
    • Ishizu, Yoji;
    • Honda, Takashi;
    • Ishikawa, Takuya;
    • Kanamori, Akira;
    • Yasuda, Satoshi;
    • Toyoda, Hidenori;
    • Yokota, Kenji;
    • Hase, Tetsunari;
    • Nishio, Naoki;
    • Maeda, Osamu;
    • Ishii, Makoto;
    • Sone, Michihiko;
    • Ando, Yuichi;
    • Akiyama, Masashi
    Publication type:
    Article
    33
    34
    35
    36

    Synthetic retinoid-mediated preconditioning of cancer-associated fibroblasts and macrophages improves cancer response to immune checkpoint blockade.

    Published in:
    British Journal of Cancer, 2024, v. 131, n. 2, p. 372, doi. 10.1038/s41416-024-02734-3
    By:
    • Owaki, Takayuki;
    • Iida, Tadashi;
    • Miyai, Yuki;
    • Kato, Katsuhiro;
    • Hase, Tetsunari;
    • Ishii, Makoto;
    • Ando, Ryota;
    • Hinohara, Kunihiko;
    • Akashi, Tomohiro;
    • Mizutani, Yasuyuki;
    • Ishikawa, Takuya;
    • Mii, Shinji;
    • Shiraki, Yukihiro;
    • Esaki, Nobutoshi;
    • Yamamoto, Masami;
    • Tsukamoto, Tetsuya;
    • Nomura, Sachiyo;
    • Murakami, Takashi;
    • Takahashi, Masahide;
    • Yuguchi, Yuri
    Publication type:
    Article
    37

    Anti-thyroid antibodies and thyroid echo pattern at baseline as risk factors for thyroid dysfunction induced by anti-programmed cell death-1 antibodies: a prospective study.

    Published in:
    2020
    By:
    • Okada, Norio;
    • Iwama, Shintaro;
    • Okuji, Takayuki;
    • Kobayashi, Tomoko;
    • Yasuda, Yoshinori;
    • Wada, Eri;
    • Onoue, Takeshi;
    • Goto, Motomitsu;
    • Sugiyama, Mariko;
    • Tsunekawa, Taku;
    • Takagi, Hiroshi;
    • Hagiwara, Daisuke;
    • Ito, Yoshihiro;
    • Suga, Hidetaka;
    • Banno, Ryoichi;
    • Hase, Tetsunari;
    • Morise, Masahiro;
    • Kanda, Mitsuro;
    • Yokota, Kenji;
    • Hashimoto, Naozumi
    Publication type:
    journal article
    38
    39

    Pharmacokinetic and dose‐finding study of osimertinib in patients with impaired renal function and low body weight.

    Published in:
    Cancer Science, 2023, v. 114, n. 5, p. 2087, doi. 10.1111/cas.15736
    By:
    • Fujiwara, Yutaka;
    • Makihara, Reiko;
    • Hase, Tetsunari;
    • Hashimoto, Naozumi;
    • Naito, Tomoyuki;
    • Tsubata, Yukari;
    • Okuno, Takae;
    • Takahashi, Toshiaki;
    • Kobayashi, Haruki;
    • Shinno, Yuki;
    • Zenke, Yoshitaka;
    • Ikeda, Takaya;
    • Hosomi, Yukio;
    • Watanabe, Kageaki;
    • Kitazono, Satoru;
    • Sakiyama, Naomi;
    • Makino, Yoshinori;
    • Yamamoto, Noboru
    Publication type:
    Article
    40
    41
    42
    43

    CEBPγ facilitates lamellipodia formation and cancer cell migration through CERS6 upregulation.

    Published in:
    Cancer Science, 2021, v. 112, n. 7, p. 2770, doi. 10.1111/cas.14928
    By:
    • Shi, Hanxiao;
    • Niimi, Atsuko;
    • Takeuchi, Toshiyuki;
    • Shiogama, Kazuya;
    • Mizutani, Yasuyoshi;
    • Kajino, Taisuke;
    • Inada, Kenichi;
    • Hase, Tetsunari;
    • Hatta, Takahiro;
    • Shibata, Hirofumi;
    • Fukui, Takayuki;
    • Chen‐Yoshikawa, Toyofumi Fengshi;
    • Nagano, Kazuki;
    • Murate, Takashi;
    • Kawamoto, Yoshiyuki;
    • Tomida, Shuta;
    • Takahashi, Takashi;
    • Suzuki, Motoshi
    Publication type:
    Article
    44

    Phase I study of vorinostat with gefitinib in BIM deletion polymorphism/epidermal growth factor receptor mutation double‐positive lung cancer.

    Published in:
    Cancer Science, 2020, v. 111, n. 2, p. 561, doi. 10.1111/cas.14260
    By:
    • Takeuchi, Shinji;
    • Hase, Tetsunari;
    • Shimizu, Shinobu;
    • Ando, Masahiko;
    • Hata, Akito;
    • Murakami, Haruyasu;
    • Kawakami, Takahiro;
    • Nagase, Katsuhiko;
    • Yoshimura, Kenichi;
    • Fujiwara, Tadami;
    • Tanimoto, Azusa;
    • Nishiyama, Akihiro;
    • Arai, Sachiko;
    • Fukuda, Koji;
    • Katakami, Nobuyuki;
    • Takahashi, Toshiaki;
    • Hasegawa, Yoshinori;
    • Ko, Tun Kiat;
    • Ong, S. Tiong;
    • Yano, Seiji
    Publication type:
    Article
    45
    46
    47
    48